We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 43

Eli Lilly Canada Inc. v. Apotex Inc (2010 FCA 240)

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • October 27 2010

This was an appeal of the decision of Madame Justice Gauthier (in the Federal Court) who had found that although Lilly met its burden to prove that Apotex infringed eight Lilly process patents related to the manufacture of the antibiotic cefaclor for material imported before June 3, 1998, Lilly failed to do so for the cefaclor imported into Canada after June 3, 1998

Novo Nordisk v. Cobalt Pharmaceuticals, S. 55.2 proceeding, Repaglinide, Aug. 3, 2010

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • August 26 2010

Cobalt served a NOA with respect to repaglinide, the S enantiomer of a previously disclosed racemic compound (the “388 compound”), alleging invalidity of the '851 patent on grounds of anticipation, obviousness and s. 53(1

Apotex loses the war in Canada and the battle in England: UK courts rely on Canadian decision to find Apotex acting unlawfully in cCnada has consequences in eErope

  • Gowling Lafleur Henderson LLP
  • -
  • Canada, United Kingdom
  • -
  • October 13 2011

Servier developed perindopril erbumine (“perindopril”) which is a successful long lasting ACE inhibitor sold under the trade-mark COVERSYL

Counterfeiters face stiff penalties in Canada

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • February 10 2014

The Office of the United States Trade Representative ("USTR") publishes a report every few years called the Special 301 Report. In the report, the

Impacts of the Amazon.com decisions on medical use claims in Canada

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • July 13 2012

Methods of medical treatment and surgery are not statutory subject matter in Canada

Eli Lilly v Novopharm, motion for reconsideration of judgment of Federal Court of Appeal (“FCA”), olanzapine, September 7, 2010

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • September 21 2010

Novopharm moved for reconsideration of the FCA's judgment allowing Lilly's appeal of a Federal Court decision that impeached Lilly's patent

An equity partner in a law firm is also an employee for the purposes of employment legislation

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • July 31 2011

The British Columbia Supreme Court upheld a Human Rights Tribunal decision that decided that an equity partner in a law firm was also an employee for the purposes of employment legislation

Pfizer v Ratiopharm, appeal of decision on invalidity, Amlodipine Besylate, July 29, 2010

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • August 26 2010

In the Federal Court, Pfizer's patent for amlodipine besylate was held invalid on numerous grounds, including obviousness

Astrazeneca v. Apotex, interlocutory motion to strike affidavit in PMNOC Regulations case

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • May 21 2010

This was an appeal to the Federal Court of Appeal (FCA) of the decision of Justice Hughes refusing to strike an affidavit from the record

AstraZeneca v Novopharm, motion to adduce video-recordings of cross-examinations of expert witnesses in a PMNOC Regulations case

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • May 21 2010

AstraZeneca brought a motion seeking an order that video-recordings of cross-examinations of expert witnesses in the proceedings be filed as part of the Application Record and available at the hearing